Using surveillance data to evaluate the effectiveness of inactivated/mRNA COVID-19 vaccine boosters in preventing fatal outcomes among severe COVID-19 cases during the current ambit of SARS-CoV-2 XBB and JN.1 variant circulation
Vaccines based on ancestral strains maintain some degree of effectiveness against recently emerged variants, offering insights for healthcare policies in regions where earlier generations of inactivated and mRNA vaccines continue to be administered.
Authors
- Karina Chan (ORCID: https://orcid.org/0000-0002-6761-4838)
- Shuk Kwan Chuang (ORCID: https://orcid.org/0000-0003-1129-7869)
- S K So
- Daniel Lo (ORCID: https://orcid.org/0000-0002-8508-9651)
- Kirran N. Mohammad (ORCID: https://orcid.org/0000-0001-6745-6262)
- Lydia Su Yin Wong (ORCID: https://orcid.org/0000-0001-6369-1281)
- Kin Hang Kung
- Eugene Siu Kai Lo (ORCID: https://orcid.org/0000-0002-1614-5832)
- Christina Y. Chan (ORCID: https://orcid.org/0000-0001-7779-0002)
- K.Y. Law
Institutions
- Department of Health (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2025-05-14
- DOI
- https://doi.org/10.3389/fpubh.2025.1497399
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00